Eyal Attar
Chief Tech/Sci/R&D Officer bij VOR BIOPHARMA INC.
Vermogen: 39 899 $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Eyal Attar
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 36 | |
| Public Company | Biotechnology | 13 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Eyal Attar via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Executive Officer Public Communications Contact Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel Chief Tech/Sci/R&D Officer | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal Human Resources Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Public Communications Contact Sales & Marketing | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Corporate Officer/Principal Director/Board Member | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Renovis, Inc.
 Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Pharmaceuticals: Major | Corporate Officer/Principal Founder | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Investor Founder Private Equity Investor | |
| AVEDRO, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| TRANSLATE BIO, INC. | Biotechnology | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Director/Board Member Doctorate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
| Boston University | College/University | Undergraduate Degree Masters Business Admin | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
| Bentley University | College/University | Graduate Degree Undergraduate Degree | |
| Boston College | College/University | Graduate Degree Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| FATE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Founder | |
The Aaron Diamond AIDS Research Center
 The Aaron Diamond AIDS Research Center Miscellaneous Commercial ServicesCommercial Services The Aaron Diamond AIDS Research Center for the City of New York, Inc. provides research and clinical testing solutions for HIV and AIDS. The firm focuses on basic science of AIDS and its related research. The company was founded by Irene Diamonds on April 16, 1991 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Harvard Medical School | College/University | Director/Board Member Corporate Officer/Principal Doctorate Degree | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Chairman Director/Board Member Director/Board Member | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| SAGE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director/Board Member Public Communications Contact | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| EDITAS MEDICINE, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| JUNO THERAPEUTICS INC | Biotechnology | Founder Director/Board Member | |
| CRISPR THERAPEUTICS AG | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| DENALI THERAPEUTICS INC. | Biotechnology | Director/Board Member Director/Board Member Founder | |
| NEON THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO | |
GRAIL LLC
 GRAIL LLC Electronic Equipment/InstrumentsElectronic Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member Director/Board Member | |
| FOGHORN THERAPEUTICS INC. | Biotechnology | Founder Chief Tech/Sci/R&D Officer | |
Tango Therapeutics Sub, Inc.
 Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO Human Resources Officer | |
| BEAM THERAPEUTICS INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| MODERNA, INC. | Biotechnology | Corporate Officer/Principal Founder | |
| SANA BIOTECHNOLOGY, INC. | Biotechnology | Founder Director/Board Member Corporate Officer/Principal | |
| DYNE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| PRIME MEDICINE, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Comptroller/Controller/Auditor Chief Operating Officer | |
| 501 ACQU | Financial Conglomerates | Director/Board Member Chief Executive Officer Director/Board Member | |
Ensoma, Inc.
 Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | Miscellaneous Commercial Services | Founder President | |
| NEUMORA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Sonata Therapeutics, Inc.
 Sonata Therapeutics, Inc. BiotechnologyHealth Technology Sonata Therapeutics, Inc. is a pioneering private company based in Cambridge, MA that designs single therapeutics to reprogram diseased cells and create curative microenvironments. The company's machine learning-based platform identifies novel insights, targets, and therapeutics across a wide range of disease areas, with a growing pipeline of small molecule drugs and genetic therapeutics. In oncology, Sonata's transformative therapies reprogram cancer cells to release curative signals that reverse immune cell suppression and blockade, empowering the immune system to holistically eradicate tumors and drive cure. Sonata Therapeutics is creating a new class of network medicines™ designed to modulate all the key cell types in a disease microenvironment required to drive disease resolution. The company is also exploring additional therapeutic areas such as fibrosis and tissue regeneration where multicellular networks play a key role. The company has subsidiaries in the United States. The company was founded in 2022 by flagship pioneering, and the CEO is Volker Herrmann. | Biotechnology | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 47 |
| Zwitserland | 3 |
| Denemarken | 2 |
| Israël | 2 |
Sectoraal
| Health Technology | 34 |
| Consumer Services | 9 |
| Finance | 5 |
| Commercial Services | 3 |
| Process Industries | 2 |
Operationeel
| Director/Board Member | 321 |
| Corporate Officer/Principal | 116 |
| Independent Dir/Board Member | 110 |
| Undergraduate Degree | 43 |
| Chairman | 36 |
Sterkste connecties
| Insiders | |
|---|---|
| Robert Nelsen | 80 |
| Douglas Cole | 44 |
| Perry Karsen | 38 |
| Joshua Resnick | 36 |
| Ian Clark | 35 |
| Kush Parmar | 32 |
| David Scadden | 26 |
| Marc Tessier-Lavigne | 24 |
| Kevin Starr | 19 |
| David Lubner | 19 |
| Jacqualyn Fouse | 18 |
| Bill Lundberg | 17 |
| May Kin Ho | 16 |
| Kaye Foster-Cheek | 16 |
| Lewis Cantley | 14 |
- Beurs
- Insiders
- Eyal Attar
- Bedrijfsconnecties
